Aralez Puts Forward Ch. 11 Plan Isolated From Toprol Sale
By Alex Wolf ( February 6, 2019, 6:14 PM EST) -- Aralez Pharmaceuticals Inc. asked a New York bankruptcy court on Tuesday to approve balloting and disclosure materials for a plan to liquidate most of its corporate entities in Chapter 11 while it sets aside a contentious fight over selling its franchise of blood pressure medication Toprol-XL to its secured lender....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.